Dr. Lorenz Jellinghaus

Dr Lorenz Jellinghaus specialises in venture capital, M&A, and corporate law. His clients include investors, founders, and family offices, whom he regularly advises on financing rounds and M&A transactions. He also has many years of experience in the field of corporate venture capital.

Also, Dr Lorenz Jellinghaus is characterised by his negotiating skills, his high level of personal commitment and his entrepreneurial thinking. He is used to managing complex projects in a determined and solution-oriented manner and thus contributes to the success of his clients.

• Mergers & acquisitions
• Venture capital / private equity
• Company law

• JUVE Handbook 2022 | 2023 and 2023 | 2024: Often recommended lawyer
  
• Handelsblatt & Best Lawyers: One of the best lawyers for corporate law (2019-2023), venture capital (2022-2023) and mergers & acquisitions (2022-2023) in Germany
• Legal 500 Germany (& EMEA) 2016 – 2021, 2024: Recommended lawyer
• Legal 500 Germany 2018, 2019: Name of the next generation for venture capital in Germany

• Lawyer at LUTZ | ABEL since 2012
• Lawyer since 2005 - before joining LUTZ | ABEL he worked for major international law firms
• Doctorate (Dr. jur.) at the Max Planck Institute for European Legal History in Frankfurt am Main (doctoral scholarship from the German Research Foundation DFG)
• Law studies in Freiburg in Breisgau and Munich

• Advising Bertelsmann SE & Co. KGaA on the sale of its stake in DDV Mediengruppe
• Advising Just Spices on the sale of its majority stake to Kraft Heinz
• Shareholder of Dracoon on sale to Kiteworks
• Dracoon on financing rounds
• Sole shareholder of Channel Pilot Solutions GmbH on majority investment by Bregal Unternehmerkapital
• Circula on series A financing round
• Advising members of the supervisory board on the sale of HSH Nordbank AG (now HCOB) to Cerberus
• EIT Health on investments and implementation of accelerator programs
• Immomio on the acquisition of DIT and on financing rounds
• Temedica on series B financing round
• ROCCAT GmbH on the sale to Turtle Beach Corporation